Navigation Links
Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
Date:6/30/2010

Therapure Biopharma Inc. today announced an agreement under which Therapure will provide development services for Diamedica Incorporated, a biopharmaceutical company based in Winnipeg, Manitoba. Under the terms of the agreement, Therapure will provide cell line development and protein production services to support clinical development for one of Diamedica’s products, a protein which may be used for the treatment of diabetes and neurological disorders. The companies are also negotiating contracts for on-going GMP manufacturing services. Financial terms were not disclosed.

Toronto, ON (Vocus) June 30, 2010 -- Therapure Biopharma Inc. today announced an agreement under which Therapure will provide development services for Diamedica Incorporated, a biopharmaceutical company based in Winnipeg, Manitoba. Under the terms of the agreement, Therapure will provide cell line development and protein production services to support clinical development for one of Diamedica’s products, a protein which may be used for the treatment of diabetes and neurological disorders. The companies are also negotiating contracts for on-going GMP manufacturing services. Financial terms were not disclosed.

DiaMedica Inc. (DiaMedica) is a Canada-based biopharmaceutical company focused on developing treatments for diseases with significant unmet need including diabetes and neurological diseases. The Company has been selected as one of Canada’s Top 10™ life science companies in 2007/2008 and 2008/2009 by the Ottawa Centre for Research and Innovation (OCRI) and has several compounds in various stages of development.

“We are proud to have been chosen by Diamedica as its partner to provide cell line development and protein production services” said Thomas Wellner, President and CEO of Therapure. “Therapure has performed similar services for a number of clients and has demonstrated market leading expertise,” continued Mr. Wellner.

'Diamedica was seeking a cell line developer with the scientific expertise to handle this specialty product,' said Rick Pauls, CEO of Diamedica Inc. 'This project is important to DiaMedica’s future success and we are confident in Therapure’s ability to meet our needs'.

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

# # #

Read the full story at http://www.prweb.com/releases/biopharma/manufacturing/prweb4204774.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Therapure Biopharma Inc. opens for business with first client contracts
2. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
3. Therapure Biopharma Inc. announces collaboration with BioVectra Inc.
4. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
5. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
6. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
7. Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers ... The result of a collaboration among several companies with expertise in toolholding, cutting ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
Breaking Biology News(10 mins):